PDE4 inhibitors vs placebo for #COPD: some benefits but side effects & little impact on symptoms or quality of life http://t.co/nxD0JUcMY0

Phosphodiesterase 4 inhibitors for chronic obstructive pulmonary disease. @CochraneLibrary http://t.co/54LlTpIo2w

PDE4 inhibitors vs placebo for #COPD: some benefits but side effects & little impact on symptoms or quality of life http://t.co/nxD0JUcMY0

PDE4 inhibitors vs placebo for #COPD: some benefits but side effects & little impact on symptoms or quality of life http://t.co/nxD0JUcMY0

PDE4 inhibitors vs placebo for #COPD: some benefits but side effects & little impact on symptoms or quality of life http://t.co/nxD0JUcMY0

PDE4 inhibitors vs placebo for #COPD: some benefits but side effects & little impact on symptoms or quality of life http://t.co/nxD0JUcMY0

Seven new studies and FDA data on psychiatric adverse events and suicides included in our PDE4 for COPD review update http://t.co/IeINMQq7QJ

Seven new studies and FDA data on psychiatric adverse events and suicides included in our PDE4 for COPD review update http://t.co/IeINMQq7QJ

Updated #CochraneEvidence on #COPD new today http://t.co/i6IbyY9On8 Here's my recent blog on other COPD reviews http://t.co/6sZjtwI4mW

Udated #Cochrane review: Phosphodiesterase 4 inhibitors for COPD http://t.co/V2q1gF9GZe

Updated #CochraneEvidence on #COPD new today http://t.co/i6IbyY9On8 Here's my recent blog on other COPD reviews http://t.co/6sZjtwI4mW

Seven new studies and FDA data on psychiatric adverse events and suicides included in our PDE4 for COPD review update http://t.co/IeINMQq7QJ

Seven new studies and FDA data on psychiatric adverse events and suicides included in our PDE4 for COPD review update http://t.co/QmxGog89vk

Udated #Cochrane review: Phosphodiesterase 4 inhibitors for COPD http://t.co/V2q1gF9GZe

updated #Cochrane review: Phosphodiesterase 4 inhibitors for COPD http://t.co/QmxGog89vk